Showing results (481-490 of 569) with videos related to

Sort By:
Pageof 57
Human Molecular Genetics|September 15, 2012
A meta-analysis of genome-wide association studies of breast cancer identifies two novel susceptibility loci at 6q14 and 20q11Afshan Siddiq, Fergus J Couch, Gary K Chen, et al.
Breast Cancer Research : BCR|August 19, 2021
Association of germline genetic variants with breast cancer-specific survival in patient subgroups defined by clinic-pathological variables related to tumor biology and type of systemic treatmentAnna Morra, Maria Escala-Garcia, Jonathan Beesley, et al.
British Journal of Cancer|August 3, 2021
Mendelian randomisation study of smoking exposure in relation to breast cancer riskHanla A Park, Sonja Neumeyer, Kyriaki Michailidou, et al.
Breast Cancer Research : BCR|January 5, 2022
Common variants in breast cancer risk loci predispose to distinct tumor subtypesThomas U Ahearn, Haoyu Zhang, Kyriaki Michailidou, et al.
Communications Biology|October 6, 2022
Copy number variants as modifiers of breast cancer risk for BRCA1/BRCA2 pathogenic variant carriersChristopher Hakkaart, John F Pearson, Louise Marquart, et al.
Plos One|November 13, 2014
MicroRNA related polymorphisms and breast cancer riskSofia Khan, Dario Greco, Kyriaki Michailidou, et al.
Human Molecular Genetics|June 15, 2014
Genetic variation in mitotic regulatory pathway genes is associated with breast tumor gradeKristen S Purrington, Seth Slettedahl, Manjeet K Bolla, et al.
Human Molecular Genetics|May 21, 2011
Low penetrance breast cancer susceptibility loci are associated with specific breast tumor subtypes: findings from the Breast Cancer Association ConsortiumAnnegien Broeks, Marjanka K Schmidt, Mark E Sherman, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 26, 2012
A nonsynonymous polymorphism in IRS1 modifies risk of developing breast and ovarian cancers in BRCA1 and ovarian cancer in BRCA2 mutation carriersYuan C Ding, Lesley McGuffog, Sue Healey, et al.
British Journal of Cancer|January 26, 2021
CYP3A7*1C allele: linking premenopausal oestrone and progesterone levels with risk of hormone receptor-positive breast cancersNichola Johnson, Sarah Maguire, Anna Morra, et al.
Pageof 57